Intellectual Developmental Disorder
8
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear.
Emotional Processes in Adults With Intellectual Developmental Disorder
Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability
Speech of Kids After Neonatal Encephalopathy
The Belgian Genome Resource to Resolve Rare Diseases
Easy-to-Read Content Effectiveness Evaluation
Better Delineation of BCL11B Related Phenotype and Epigenetic Signature.
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature.